Multiple sclerosis: a two-stage disease

被引：476

作者：

Steinman, L ^{[1
]}

机构：

[1] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA

来源：

NATURE IMMUNOLOGY | 2001年 / 2卷 / 09期

关键词：

D O I：

10.1038/ni0901-762

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

The pathogenesis of multiple sclerosis consists of an inflammatory and neurodegnerative phase. Better understanding of these stages has aided the development of specific therapeutic targets.

引用

页码：762 / 764

页数：3

共 10 条

[1] The immunobiology of multiple sclerosis: An autoimmune disease of the central nervous system [J].

Conlon, P ;

Oksenberg, JR ;

Zhang, JQ ;

Steinman, L .

NEUROBIOLOGY OF DISEASE, 1999, 6 (03) :149-166

[2] A full genome search in multiple sclerosis [J].

Ebers, GC ;

Kukay, K ;

Bulman, DE ;

Sadovnick, AD ;

Rice, G ;

Anderson, C ;

Armstrong, H ;

Cousin, K ;

Bell, RB ;

Hader, W ;

Paty, DW ;

Hashimoto, S ;

Oger, J ;

Duquette, P ;

Warren, S ;

Gray, T ;

OConnor, P ;

Nath, A ;

Auty, A ;

Metz, L ;

Francis, G ;

Paulseth, JE ;

Murray, TJ ;

PrysePhillips, W ;

Nelson, R ;

Freedman, M ;

Brunet, D ;

Bouchard, JP ;

Hinds, D ;

Risch, N .

NATURE GENETICS, 1996, 13 (04) :472-476

[3] A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex [J].

Haines, JL ;

TerMinassian, M ;

Bazyk, A ;

Gusella, JF ;

Kim, DJ ;

Terwedow, H ;

PericakVance, MA ;

Rimmler, JB ;

Haynes, CS ;

Roses, AD ;

Lee, A ;

Shaner, B ;

Menold, M ;

Seboun, E ;

Fitoussi, RP ;

Gartioux, C ;

Reyes, C ;

Ribierre, F ;

Gyapay, G ;

Weissenbach, J ;

Hauser, SL ;

Goodkin, DE ;

Lincoln, R ;

Usuku, K ;

GarciaMerino, A ;

Gatto, N ;

Young, S ;

Oksenberg, JR .

NATURE GENETICS, 1996, 13 (04) :469-471

[4] Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial [J].

Kappos, L ;

Comi, G ;

Panitch, H ;

Oger, J ;

Antel, J ;

Conlon, P ;

Steinman, L .

NATURE MEDICINE, 2000, 6 (10) :1176-1182

[5]

LOSEFF NA, 1996, BRAIN, V119, P701

[6] Distinct patterns of multiple sclerosis pathology indicates heterogeneity in pathogenesis [J].

Lucchinetti, CF ;

Bruck, W ;

Rodriguez, M ;

Lassmann, H .

BRAIN PATHOLOGY, 1996, 6 (03) :259-274

[7] Glutamate excitotoxicity in a model of multiple sclerosis [J].

Pitt, D ;

Werner, P ;

Raine, CS .

NATURE MEDICINE, 2000, 6 (01) :67-70

[8] A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22 [J].

Sawcer, S ;

Jones, HB ;

Feakes, R ;

Gray, J ;

Smaldon, N ;

Chataway, J ;

Robertson, N ;

Clayton, D ;

Goodfellow, PN ;

Compston, A .

NATURE GENETICS, 1996, 13 (04) :464-468

[9] Axonal transection in the lesions of multiple sclerosis [J].

Trapp, BD ;

Peterson, J ;

Ransohoff, RM ;

Rudick, R ;

Mörk, S ;

Bö, L .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (05) :278-285

[10] Recognition of the immunodominant myelin basic protein peptide by autoantibodies and HLA-DR2-restricted T cell clones from multiple sclerosis patients - Identity of key contact residues in the B-cell and T-cell epitopes [J].

Wucherpfennig, KW ;

Catz, I ;

Hausmann, S ;

Strominger, JL ;

Steinman, L ;

Warren, KG .

JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (05) :1114-1122

← 1 →